You are welcome to believe that Anavex made up its story of how Anavex 2-73 re-connects mitochondria and endoplasmic reticula.
If it's false, as you imply, the SEC needs to learn of this, as this would be a major, confounding, and illegal misrepresentation of the company's major drug candidate, affecting AVXL stock prices, etc.
Of course, there have been no adverse or negating responses from the many neuro-scientists who have scrutinized Anavex presentations, such as this one. No top-line biochemistry or neuron function parties have --- unlike a number of posters here --- shouted expressions of warning and falsehoods regarding the presented and posted Anavex data. The absence of contravening scientific presentations or expressions of such by competent neuroscientists (not high school biology teachers; me) is rather defining.
Again, if anyone would (or could), please post expert opinion or published data telling how Anavex 2-73 simply can't function as the company describes, by re-connecting mitochondria and rough endoplasmic reticula, thereby restoring their normalized functions and cellular homeostasis.
Many, quite understandably, question the degree of my expertise on Anavex neuron chemistry and physiology. But, if I'm all wrong on this, telling exactly what the company itself tells in its posted presentations and scientific meetings presentations, just why haven't any real experts (impartial professional scientists) laid out for all of us the errors of Anavex presentations?
Simple. Those who can comprehend the documented, detailed science of the matter find no errors, no misrepresentations by Anavex.
Each is welcome to follow the perspectives of Ihub posters (of all sorts; me and others), Anavex presentations, and/or true experts. The true experts have been utterly silent regarding the implied misrepresentations of Anavex Life Sciences Corp.
